May is American Stroke Month
May is American Stroke Month. Check out the MedlinePlus stroke topic page, which includes interactive tutorials on stroke prevention and stroke rehabilitation . Also, learn more by reading the latest news.
May is American Stroke Month. Check out the MedlinePlus stroke topic page, which includes interactive tutorials on stroke prevention and stroke rehabilitation . Also, learn more by reading the latest news.
Watch a live webcast of a total knee replacement surgery on May 2 at 12 p.m. EDT.
Also, browse through links to prerecorded webcasts of surgical procedures. These are actual procedures performed at medical centers in the United States.
Glaxo: FDA OKs Advair 250/50 to reduce exacerbations in COPD patients Interactive Investor, UK - Apr 30, 2008 COPD is a progressive, life-threatening lung disease that includes chronic bronchitis, emphysema or both. With this approval, Advair becomes the only ... |
GSK Says FDA Approved Advair 250/50 For Reduction Of Exacerbations ... RTT News, NY - 11 minutes ago ... inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations. ... |
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in ... SunHerald.com, MS - 15 minutes ago With this approval, Advair becomes the only treatment FDA has approved to reduce COPD exacerbations. Treatment guidelines for COPD state that the reduction ... |
Glaxo wins US FDA approval for wider Advair use Reuters - 39 minutes ago N: Quote, Profile, Research) Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the drugmaker ... |
The Safety of ECT in Patients With Chronic Obstructive Pulmonary ... Psychosomatics (subscription) - Apr 30, 2008 Very little has been written about the safety and management strategy of ECT patients with chronic obstructive pulmonary disease (COPD). ... |
The Safety of ECT in Patients With Chronic Obstructive Pulmonary ... Psychosomatics (subscription) - 4 hours ago Very little has been written about the safety and management strategy of ECT patients with chronic obstructive pulmonary disease (COPD). ... |
SOURCE: St. Luke's - Roosevelt Hospital Center Market Wire (press release) - Apr 30, 2008 "Alpha-1 is the most significant genetic risk factor for COPD (chronic obstructive pulmonary disease), which the fourth leading cause of death in America ... |
SOURCE: St. Luke's - Roosevelt Hospital Center Market Wire (press release) - 6 hours ago "Alpha-1 is the most significant genetic risk factor for COPD (chronic obstructive pulmonary disease), which the fourth leading cause of death in America ... |